Phathom spikes as Cantor Fitzgerald bullish on IP claims
Phathom Pharmaceuticals (NASDAQ:PHAT) traded higher on Friday after Cantor Fitzgerald initiated its coverage with an overweight recommendation despite a recent selloff attributed to the company's IP ...
Cantor Fitzgerald maintains $118 target on Ultragenyx stock
Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...
Phathom Pharmaceuticals initiated at Cantor Fitzgerald on ‘significant’ upside
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...
Seabridge Gold Announces US$100 Million in Financings Includes US$20 million from Strategic Investor
Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) ("Seabridge" or the "Company") announced today it has entered into an agreement with RBC Capital Markets and Cantor Fitzgerald Canada Corporation (together ...
Cantor Fitzgerald Remains a Buy on Kornit Digital (KRNT)
In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Kornit Digital (KRNT – Research Report), with a ...
CVS Health upgraded at Cantor Fitzgerald after Q4 beat
CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...
Rejuvenation of a Sharp Employer Non-Compete Tool: Delaware Supreme Court Reinvigorates the Employee Choice Doctrine
The authors write "Post-employment restrictive covenants, once viewed as near fortresses to protect proprietary information, ...
Trump Taps McKinsey CLO Pierre Gentin for Commerce Department GC
President Trump has nominated Pierre Gentin, chief legal officer of the consulting giant McKinsey & Co. since 2019, to serve ...
Vanda Pharmaceuticals And Anaptys Announce Exclusive Global License Agreement For Vanda To Develop And Commercialize Imsidolimab, An IL-36R Antagonist
Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...
Yahoo Finance14d
Cigna price target lowered to $350 from $400 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...
Stockhouse14d
Ucore Accepts $2M Investment from Hondo Private Equity LLC
Halifax, Nova Scotia--(Newsfile Corp. - January 31, 2025) - Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) ("Ucore" or the "Company") is pleased to ... Mr. Matthews was CEO of Cantor Fitzgerald & ...
bnnbloomberg14d
Stablecoin Issuer Tether Says Profit Was $13 Billion Last Year
Howard Lutnick, the president’s nominee, is the head of Cantor Fitzgerald LP, which serves as a key banking ... are limited to a snapshot in time and do not allow full access to a company’s books. The ...